Blood test may spot hidden artery risk in dialysis patients

NCT ID NCT07179211

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at 120 adults on regular hemodialysis to see if a simple blood test called the neutrophil-to-lymphocyte ratio (NLR) can help detect peripheral artery disease (PAD). PAD is a common but often overlooked complication in kidney patients. The goal is to find a cheap, easy way to identify those at higher risk, so they can get help sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple, low-cost blood test to help identify hemodialysis patients at risk for peripheral artery disease, allowing for earlier monitoring and care.

What could go wrong

This is an observational study, not a treatment trial. It only looks for a link between a blood marker and disease, so it won't directly improve health. The results may not apply to all patient groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sohag faculty

    Sohag, Egypt